WealthShield Partners LLC Grows Stock Position in UnitedHealth Group Incorporated $UNH

WealthShield Partners LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 13,382 shares of the healthcare conglomerate’s stock after purchasing an additional 2,303 shares during the quarter. WealthShield Partners LLC’s holdings in UnitedHealth Group were worth $4,418,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. Beacon Financial Strategies CORP purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $26,000. Joseph Group Capital Management purchased a new position in UnitedHealth Group during the 4th quarter worth $27,000. Foster Dykema Cabot & Partners LLC grew its position in shares of UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 34 shares in the last quarter. 1248 Management LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at about $29,000. Finally, Holos Integrated Wealth LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $29,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.9%

UNH stock opened at $367.11 on Thursday. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $395.52. The stock has a market capitalization of $333.41 billion, a PE ratio of 27.73, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The firm has a 50 day moving average of $302.62 and a 200 day moving average of $316.89.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is 66.77%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Oppenheimer increased their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Erste Group Bank raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective on the stock in a research report on Tuesday, April 7th. TD Cowen raised their price target on shares of UnitedHealth Group from $311.00 to $337.00 and gave the company a “hold” rating in a report on Thursday, April 23rd. Finally, Truist Financial reaffirmed a “buy” rating and issued a $395.00 price target (up from $370.00) on shares of UnitedHealth Group in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $378.88.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Zacks Research raised near?term and FY?2026 EPS forecasts (Q2 2026 to $4.94 from $4.74; FY?2026 to $18.26), signaling stronger near?term earnings momentum and reinforcing consensus that 2026 will be a recovery year. (Zacks estimate revisions — MarketBeat / summary)
• Positive Sentiment: UnitedHealthcare will eliminate prior?authorization requirements for roughly 30% of services starting in 2026 — a large operational change that should reduce administrative friction, improve member/provider experience and potentially lower costs over time. This is being viewed favorably by the market. UnitedHealth Prior Authorization Shift And What It Could Mean For UNH Stock
• Positive Sentiment: Goldman Sachs added UNH to its U.S. Conviction List and kept a $435 price target — a high?profile vote of confidence that likely supports buying interest. Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target
• Positive Sentiment: Managerial actions and fundamentals: analysts and commentators point to increased share buybacks and an improved Q1 that lifted guidance — themes that support multiple expansion and investor confidence. Why UnitedHealth Group Stock Came Roaring Back In April
• Neutral Sentiment: Sector context — peers Tenet (THC) beat Q1 but face payer?mix pressure, and CVS reported strong Health Benefits results tied to ACA exits/premium actions; these moves can influence industry pricing and utilization dynamics but are not direct UNH fundamentals. THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups ’26 EPS View CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
• Neutral Sentiment: Talent movement: a former UnitedHealth executive, Heather Cianfrocco, was appointed COO at Highmark — notable for industry networking but not currently viewed as material to UNH’s strategy. Highmark Health Appoints Heather Cianfrocco as Chief Operating Officer
• Negative Sentiment: Zacks also trimmed a few longer?term quarter/year estimates (small cuts to FY?2027 and Q1?2028), which could temper upside expectations for distant?out periods even as near?term outlook improved.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.